NMS · Medical - Devices

OFIX (OFIX) Stock

$11.78 -0.08% NMS: OFIX Healthcare

Valuation

MetricValue
Price$11.78
Market Cap$476.17M
P/E Ratio-5.30
P/B Ratio1.09
P/S Ratio0.59
EPS (TTM)$-2.28
52-Week High$16.99
52-Week Low$8.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-20.44%
ROA-10.81%
ROCE-15.11%
Gross Margin-8.39%
Operating Margin-8.27%
Net Margin-7.27%
Debt/Equity0.54
Current Ratio2.45

Annual Financials (USD)

Metric20212022202320242025
Revenue$464.0M$461.0M$747.0M$799.0M$822.0M
Operating Profit$-8.0M$-13.0M$-139.0M$-85.0M$-68.0M
Net Profit$-38.0M$-20.0M$-151.0M$-126.0M$-92.0M
EPS$-1.95$-0.98$-4.12$-3.30$-2.28
Op Margin-1.8%-2.9%-18.6%-10.6%-8.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$477.0M$459.0M$925.0M$893.0M$851.0M
Total Liabilities$140.0M$122.0M$327.0M$390.0M$401.0M
Cash$88.0M$51.0M$33.0M$83.0M$82.0M
Borrowings$24.0M$22.0M$117.0M$180.0M$229.0M

Latest News

Orthofix to Report Second Quarter 2026 Financial Results Business Wire · Jul 15, 2026 Sector Update: Healthcare Stocks Fall Late Afternoon MT Newswires · Jul 6, 2026 Sector Update: Healthcare MT Newswires · Jul 6, 2026 Orthofix Medical Shares Rise After Medicare Billing for Bone Growth Stimulators Expected to Return to Prior Rates MT Newswires · Jul 6, 2026 Barrington Raises Price Target on Orthofix Medical to $17 From $15, Keeps Outperform Rating MT Newswires · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$18.0M$-12.0M$-46.0M$26.0M$33.0M
Investing Cash Flow$-43.0M$-48.0M$-95.0M$-62.0M$-69.0M
Financing Cash Flow$-12.0M$-2.0M$-8.0M$-10.0M$-6.0M
Net Cash Flow$-9.0M$-37.0M$-13.0M$48.0M$-1.0M
Free Cash Flow$-1.0M$-35.0M$-108.0M$-9.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield-0.74%
Quick Ratio1.76
Interest Coverage-4.00
Return 1Y-4.70%
Return 3Y-45.15%
Return 5Y-71.09%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABSI $7.13 -5.69% -11.32 $1.21B 0.00%
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
BFLY $8.28 -1.72% -60.65 $2.20B 0.00%
DRIO $7.47 -4.11% -10.51 $54.62M 0.00%
ESPR $3.18 +0.00% -131.40 $661.15M 0.00%

About OFIX

OFIX is led by CEO Massimo Calafiore, employs 1,616 people, headquartered in US, publicly traded since 1992.

OFIX stock trades at $11.78 with a market capitalization of $476.17M. The stock is valued at a price-to-earnings (P/E) ratio of -5.30, price-to-book of 1.09, price-to-sales of 0.59. Over the past 52 weeks the stock has ranged between $8.95 and $16.99, and currently trades 30.7% below its 52-week high.

On profitability, OFIX generates a return on equity (ROE) of -20.44%, return on capital employed of -15.11%, an operating margin of -8.27%, a net profit margin of -7.27%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides